September, 2024
September 2024
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
30  
Tom Powles on the NADINA trial
May 23, 2024, 13:04

Tom Powles on the NADINA trial

Tom Powles, Director of Barts Cancer Center, shared a post on X:

The NADINA trial of neoadjuvant ipi/nivo vs adjuvant nivo in melanoma is a plenary ASCO24 . Shorter periods of therapy in responders (neoadjuvant alone) is an important question. Neoadjuvant nivo didn’t work in RCC (PROSPER). PACIFIC2 struggled in lung.

Tom Powles

Read further.
Source: Tom Powles/X